Abstract
Preliminary Results from an Ongoing Phase 1/2 Study of INCB053914, a Pan-Proviral Integration Sites for Moloney Virus (PIM) Kinase Inhibitor, in Patients with Advanced Hematologic Malignancies
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have